Common Contracts
2 similar Accession Agreement contracts by CureVac N.V., Dievini Hopp BioTech Holding GmbH & Co KG
2nd Supplement to the Shareholders’ Agreement in relation to the Parties’ share portfolios in CureVac N.V. (NL-Amsterdam) dated 16 June 2020 as amended by the 1st Supplement dated 14 August 2020 between KfW Palmengartenstr. 5-9 60325 Frankfurt am Main...Accession Agreement • January 13th, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Pharmaceutical preparations
A On 16 June 2020, the Parties (except for DH-LT) entered into a shareholders’ agreement in relation to the Parties’ share portfolios in CureVac N.V. (NL-Amsterdam). DH-LT acceded to such shareholders’ agreement under a supplement to the shareholders’ agreement dated 14 August 2020 (“1st Supplement”) (the shareholders’ agreement as amended by the 1st Supplement is referred to as the “Shareholders’ Agreement”).
Non-binding convenience translation from German into EnglishAccession Agreement • January 13th, 2022 • CureVac N.V. • Pharmaceutical preparations
A On 16 June 2020, the Parties (except for DH-LT) entered into a shareholders’ agreement in relation to the Parties’ share portfolios in CureVac N.V. (NL-Amsterdam). DH-LT acceded to such shareholders’ agreement under a supplement to the shareholders’ agreement dated 14 August 2020 (“1st Supplement”) (the shareholders’ agreement as amended by the 1st Supplement is referred to as the “Shareholders’ Agreement”).
